Steward Partners Investment Advisory’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

Steward Partners Investment Advisory’s Portfolio ICPT Stock Details ICPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-35	Closed	-$2K	–	2889
2020 Q2	$2K	Sell	35 -40	-53%	-$3.09K	﹤0.01%	2516
2020 Q1	$4K	Hold	75	–	–	﹤0.01%	2178
2019 Q4	$9K	Sell	75 -200	-73%	-$17.9K	﹤0.01%	2073
2019 Q3	$18K	Buy	275 +200	+267%	+$13.4K	﹤0.01%	1768
2019 Q2	$5K	Buy	+75	New	+$6.71K	﹤0.01%	2248
2018 Q4	–	Sell	-142	Closed	-$18K	–	2304
2018 Q3	$18K	Hold	142	–	–	﹤0.01%	1619
2018 Q2	$12K	Buy	142 +54	+61%	+$3.95K	﹤0.01%	1681
2018 Q1	$5K	Sell	88 -67	-43%	-$4.04K	﹤0.01%	1821
2017 Q4	$9K	Hold	155	–	–	﹤0.01%	1384
2017 Q3	$8K	Sell	155 -11	-7%	-$1.19K	﹤0.01%	1184
2017 Q2	$20K	Hold	166	–	–	﹤0.01%	871
2017 Q1	$18K	Buy	+166	New	+$19.4K	﹤0.01%	794

Other funds holding ICPT

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

SCM

Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return

Steward Partners Investment Advisory's ICPT Position: Q3 2020 in Review

Steward Partners Investment Advisory sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q3 2020, closing a stake of 35 shares — an estimated $2K sold.

Steward Partners Investment Advisory first reported a position in ICPT in Q1 2017 and held it in 12 quarters. The position peaked at $20K in Q2 2017. 177 funds tracked by Wall St. Rank hold ICPT as of Q3 2020.

Steward Partners Investment Advisory reported no remaining Intercept Pharmaceuticals, Inc. position as of Q3 2020 after selling out during the quarter.
Steward Partners Investment Advisory sold 35 Intercept Pharmaceuticals, Inc. shares in Q3 2020, an estimated $2K.
Steward Partners Investment Advisory first reported a position in Intercept Pharmaceuticals, Inc. in Q1 2017 and held it in 12 quarters.
Steward Partners Investment Advisory's Intercept Pharmaceuticals, Inc. position peaked at $20K in Q2 2017.
177 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q3 2020.

Based on Steward Partners Investment Advisory's 13F filing for Q3 2020, filed 30 Oct 2020.